Overview

Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section

Status:
Completed
Trial end date:
2019-07-15
Target enrollment:
Participant gender:
Summary
the primary objective of the study is to compare the onset and recovery times of sensory and motor blockade of the two study drugs intrathecally with low dose bupivacaine The secondary objectives of the study are to observe hemodynamics, side effects profile, and duration of postoperative analgesia
Phase:
N/A
Details
Lead Sponsor:
Dow University of Health Sciences
Treatments:
Bupivacaine
Dexmedetomidine
Fentanyl